Topic : Congresses and Events Featured

Other Topics :

Congresses and Events landing description

We will regularly be attending conferences related to CML. Here is the latest news and our reports from these conferences.
Continue Reading →

ASCO 2016 – Hidden benefits of more frequent testing

During treatment for chronic myelogenous leukemia (CML), frequent tests are needed to determine how well people are responding to their medication. Key response “milestones” have identified that an earlier, more profound response translates to a better outcome over the longer term.
Continue Reading →

ASCO 2016: Stopping treatment – findings of the largest study to date

Treatment-free remission – the possibility that some people may be able to stop taking their medication – is the hottest topic in CML research. The idea is that if you can achieve a deep enough response to a medication, the leukemia will be so suppressed that it won’t be able
Continue Reading →